Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network

Mantle cell lymphoma is characterised by a poor long-term prognosis. The European Mantle Cell Lymphoma Network aimed to investigate whether the introduction of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation (ASCT) improves outcome.

Gespeichert in:
Autor*in:

Hermine, Olivier [verfasserIn]

Hoster, Eva

Walewski, Jan

Bosly, André

Stilgenbauer, Stephan

Thieblemont, Catherine

Szymczyk, Michal

Bouabdallah, Reda

Kneba, Michael

Hallek, Michael

Salles, Gilles

Feugier, Pierre

Ribrag, Vincent

Birkmann, Josef

Forstpointner, Roswitha

Haioun, Corinne

Hänel, Mathias

Casasnovas, René Olivier

Finke, Jürgen

Peter, Norma

Bouabdallah, Kamal

Sebban, Catherine

Fischer, Thomas

Dührsen, Ulrich

Metzner, Bernd

Maschmeyer, Georg

Kanz, Lothar

Schmidt, Christian

Delarue, Richard

Brousse, Nicole

Klapper, Wolfram

Macintyre, Elizabeth

Delfau-Larue, Marie-Hélène

Pott, Christiane

Hiddemann, Wolfgang

Unterhalt, Michael

Dreyling, Martin

Format:

E-Artikel

Sprache:

Englisch

Erschienen:

2016

Umfang:

11

Übergeordnetes Werk:

Enthalten in: Effects of shape functions on flexural–torsional buckling of fixed circular arches - Dou, Chao ELSEVIER, 2013, London [u.a.]

Übergeordnetes Werk:

volume:388 ; year:2016 ; number:10044 ; day:6 ; month:08 ; pages:565-575 ; extent:11

Links:

Volltext

DOI / URN:

10.1016/S0140-6736(16)00739-X

Katalog-ID:

ELV019051301

Nicht das Richtige dabei?

Schreiben Sie uns!